Malignant pleural mesothelioma: Current status and future projections in Turkey

A. Salih Emri (Ankara, Turkey), Ozge Yavuz, Salih Emri

Source: International Congress 2015 – Mediastinal tumors, malignant pleural mesothelioma and other rare tumors
Session: Mediastinal tumors, malignant pleural mesothelioma and other rare tumors
Session type: Thematic Poster Session
Number: 4317
Disease area: Thoracic oncology

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Salih Emri (Ankara, Turkey), Ozge Yavuz, Salih Emri. Malignant pleural mesothelioma: Current status and future projections in Turkey. Eur Respir J 2015; 46: Suppl. 59, 4317

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Pleural mesothelioma: Our experience in 132 cases
Source: International Congress 2014 – Diagnosis and treatment of pleural mesothelioma
Year: 2014


Solitary fibrous tumour of the pleural: Two malignant cases
Source: International Congress 2015 – Mediastinal tumors, malignant pleural mesothelioma and other rare tumors
Year: 2015


Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma
Source: Guideline 2010
Year: 2010


Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma
Source: Eur Respir J 2010; 35: 479-495
Year: 2010



A requirement for kras signaling in malignant pleural effusion
Source: Annual Congress 2013 –Fundamental biology of malignant pleural effusions
Year: 2013

Haematologic parameters and their prognostic impact in malignant pleural mesothelioma
Source: International Congress 2014 – Diagnosis of pleural effusions and mediastinal adenopathies
Year: 2014

Blood-staining of pleural fluid is an inaccurate predictor of pleural malignancy
Source: International Congress 2015 – Malignant pleural effusions and mesothelioma
Year: 2015


Malignant pleural effusion as the initial manifestation of gynecological malignancies
Source: International Congress 2016 – Malignant pleural disease: diagnosis and management
Year: 2016


The role of a pleural service in optimising pleural disease management
Source: International Congress 2014 – Diagnosis of pleural effusions and mediastinal adenopathies
Year: 2014

A novel pleural-bladder pump for management of pleural effusion
Source: Annual Congress 2013 –Clinical problems in mediastinal and pleural malignacies
Year: 2013

Malignant mesothelioma vs metastatic carcinoma of pleura: Do pathology and radiology agree?
Source: Annual Congress 2013 –Morphologic imaging
Year: 2013

CT scanner for the pleural staging of pleural cancer: How accurate is this?
Source: International Congress 2014 – Diagnosis of pleural effusions and mediastinal adenopathies
Year: 2014

Characteristics of malignant pleural effusions. Review of one-year data from a large tertiary centre
Source: Annual Congress 2013 –Diagnosis and management of pleural and mediastinal diseases
Year: 2013


Sclerosing hemangioma of the lung: Report of 4 cases
Source: International Congress 2015 – Thoracic oncology around the world: rare cases and local features
Year: 2015

Role of tumor derived versican in experimental malignant pleural mesothelioma
Source: International Congress 2016 – Mesothelioma and pleural disease: from the bench to the bedside
Year: 2016

Survival analysis of pleural malignant mesothelioma (MM) at a single Institution in Liguria, Italy
Source: International Congress 2015 – Malignant pleural effusions and mesothelioma
Year: 2015


Primary melanoma of bronchus: Report of 4 cases
Source: Annual Congress 2013 –Other thoracic tumours, particular circumstances and rare cases
Year: 2013


Pericardiodesis in pericardial tamponade
Source: International Congress 2014 – Diagnosis of pleural effusions and mediastinal adenopathies
Year: 2014


An examination of the factors for successful pleurodesis against malignant pleural effusion (MPE)
Source: International Congress 2016 – Mesothelioma and malignant pleural disease
Year: 2016


A myeloid NF-κbeta response in malignant pleural effusion
Source: Annual Congress 2013 –Fundamental biology of malignant pleural effusions
Year: 2013